Mercell Holding - Approval and publication of prospectus, and admission to trading on the Oslo Stock Exchange's main list
Oslo, 8 July 2021: Reference is made to the announcement by the Oslo Stock Exchange on 7 July 2021 regarding the approval of the transfer of listing of the shares in Mercell Holding ASA (the "Company") from trading on Euronext Growth Oslo to the Oslo Stock Exchange's main list.
The first day of trading of the Company's shares on the Oslo Stock Exchange's main list is expected to be on or about 9 July 2021. Consequently, the last day of trading of the Company's shares on Euronext Growth Oslo is expected to be today, on 8 July 2021.
The Company has prepared a prospectus in connection with the listing of its shares on the Oslo Stock Exchange (the "Prospectus"). The Prospectus was approved by the Norwegian Financial Supervisory Authority today, on 8 July 2021, and is available at the Company's web page https://investor.mercell.com/reports-and-presentations/. Hard copies of the Prospectus may be obtained free of charge at the Company's registered business address at Askekroken 11, 0277 Oslo, Norway (subject to the at all times prevailing restrictions due to the COVID-19 pandemic).
For further information please contact:
CFO Fredrik Eeg
Cell: +47 90 83 33 78
Email: Fredrik.eeg@mercell.com
This is Mercell:
Mercell is a leading digital platform for public eTendering and entered the eProcurement market in 2020. The company has approximately 3,000 buyers and some 26,000 suppliers as customers. Mercell's unique marketplace simplifies the tender and procurement process and makes it easy and secure for buyers to find relevant suppliers for their tenders and purchasing needs, and enables suppliers to find relevant business opportunities and receive and handle purchases from public and private buyers. Mercell delivers services to public and private buyers in 13 European countries with the goal of becoming the leading software-as-a-service (SaaS)-platform for eTendering and eProcurement in Europe. Through the acquisition of Negometrix in February 2021, Mercell also became market leader in the Netherlands and established a foothold in the US market.